Stamford, CT, United States of America

Mark Hatcher

USPTO Granted Patents = 9 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Mark Hatcher: Innovating through Patents in Pharmaceutical Chemistry

Introduction

Mark Hatcher, an accomplished inventor based in Stamford, CT, has made significant contributions to the field of pharmaceutical chemistry. With a total of 8 patents to his name, Hatcher has focused primarily on innovative processes in drug synthesis, showcasing his dedication to improving therapeutic options.

Latest Patents

Among his notable inventions is the synthesis of nirogacestat, a small molecule designed for potential therapeutic applications. The patent details processes for synthesizing (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide, contributing to advancements in this crucial area of medicinal chemistry.

Career Highlights

Hatcher's professional journey includes impactful tenures at Springworks Therapeutics, Inc., where he utilized his expertise to drive forward projects in drug development. His innovation in drug synthesis has positioned him as a notable figure in the industry.

Collaborations

Throughout his career, Mark Hatcher has collaborated with talented professionals, such as Kristin Patterson and Piero L Ruggiero. These partnerships have allowed for the sharing of ideas and expertise, further enhancing his contributions to the field of pharmaceutical science.

Conclusion

Mark Hatcher's work exemplifies the spirit of innovation in pharmaceutical chemistry. With 8 patents under his belt, his efforts in synthesizing crucial compounds like nirogacestat not only highlight his technical skills but also his commitment to advancing treatment options. As he continues his journey, Hatcher remains a key player in shaping the future of drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…